These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3416297)

  • 1. Melphalan transport, glutathione levels, and glutathione-S-transferase activity in human medulloblastoma.
    Friedman HS; Skapek SX; Colvin OM; Elion GB; Blum MR; Savina PM; Hilton J; Schold SC; Kurtzberg J; Bigner DD
    Cancer Res; 1988 Oct; 48(19):5397-402. PubMed ID: 3416297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents.
    Friedman HS; Colvin OM; Skapek SX; Ludeman SM; Elion GB; Schold SC; Jacobsen PF; Muhlbaier LH; Bigner DD
    Cancer Res; 1988 Aug; 48(15):4189-95. PubMed ID: 3390813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide resistance in medulloblastoma.
    Friedman HS; Colvin OM; Kaufmann SH; Ludeman SM; Bullock N; Bigner DD; Griffith OW
    Cancer Res; 1992 Oct; 52(19):5373-8. PubMed ID: 1356617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
    Skapek SX; Colvin OM; Griffith OW; Elion GB; Bigner DD; Friedman HS
    Cancer Res; 1988 May; 48(10):2764-7. PubMed ID: 3359437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
    Rosenberg MC; Colvin OM; Griffith OW; Bigner SH; Elion GB; Horton JK; Lilley E; Bigner DD; Friedman HS
    Cancer Res; 1989 Dec; 49(24 Pt 1):6917-22. PubMed ID: 2582434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermia-induced enhancement of melphalan activity against a melphalan-resistant human rhabdomyosarcoma xenograft.
    Laskowitz DT; Elion GB; Dewhirst MW; Griffith OW; Savina PM; Blum MR; Prescott DM; Bigner DD; Friedman HS
    Radiat Res; 1992 Feb; 129(2):218-23. PubMed ID: 1734453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan.
    Friedman HS; Dolan ME; Kaufmann SH; Colvin OM; Griffith OW; Moschel RC; Schold SC; Bigner DD; Ali-Osman F
    Cancer Res; 1994 Jul; 54(13):3487-93. PubMed ID: 8012971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma.
    Groothuis DR; Lippitz BE; Fekete I; Schlageter KE; Molnar P; Colvin OM; Roe CR; Bigner DD; Friedman HS
    Cancer Res; 1992 Oct; 52(20):5590-6. PubMed ID: 1394182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental chemotherapy of human medulloblastoma with classical alkylators.
    Friedman HS; Colvin OM; Ludeman SM; Schold SC; Boyd VL; Mulhbaier LH; Bigner DD
    Cancer Res; 1986 Jun; 46(6):2827-33. PubMed ID: 3698009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent exposure of medulloblastoma cells to topotecan produces growth inhibition equivalent to continuous exposure.
    Danks MK; Pawlik CA; Whipple DO; Wolverton JS
    Clin Cancer Res; 1997 Oct; 3(10):1731-8. PubMed ID: 9815557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
    Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF
    Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic analysis of melphalan-resistant human rhabdomyosarcoma xenograft TE-671 MR.
    Lilley ER; Elion GB; Dewhirst MW; Schold SC; Blum MR; Savina PM; Laskowitz DT; Bigner DD; Friedman HS
    Cancer Res; 1991 Aug; 51(15):3906-9. PubMed ID: 1855207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
    Caffrey PB; Zhang Y; Frenkel GD
    Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
    Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
    Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential specificity of monochlorobimane for isozymes of human and rodent glutathione S-transferases.
    Cook JA; Iype SN; Mitchell JB
    Cancer Res; 1991 Mar; 51(6):1606-12. PubMed ID: 1998951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-transit melanoma: the role of alkylating-agent resistance in regional therapy.
    Grubbs EG; Abdel-Wahab O; Cheng TY; Abdel-Wahab Z; Peterson B; Pruitt SK; Colvin OM; Friedman HS; Tyler DS
    J Am Coll Surg; 2004 Sep; 199(3):419-27. PubMed ID: 15325612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro versus in vivo correlations of chemosensitivity of human medulloblastoma.
    Friedman HS; Schold SC; Muhlbaier LH; Bjornsson TD; Bigner DD
    Cancer Res; 1984 Nov; 44(11):5145-9. PubMed ID: 6488174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalan.
    Moscow JA; Swanson CA; Cowan KH
    Br J Cancer; 1993 Oct; 68(4):732-7. PubMed ID: 8398701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft.
    Lilley ER; Rosenberg MC; Elion GB; Colvin OM; Bigner DD; Friedman HS
    Cancer Res; 1990 Jan; 50(2):284-7. PubMed ID: 2295068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.